| Filed On | Filing |
|---|---|
| 16 Nov 2026 | SCHEDULE 13G/A |
| 16 Nov 2026 | SCHEDULE 13G/A |
| 12 Nov 2026 | 10-Q |
| 12 Nov 2026 |
8-K: Results of Operations and Financial Condition
SAN FRANCISCO — November 12, 2026 – Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), the leader in AI technology for diagnosing and managing coronary artery disease (CAD), today reported financial results for the third quarter ended September... |
| 10 Nov 2026 |
Form 4: Farquhar John C.m., Director
Gave up 7,751 shares to cover exercise price or tax ($406K) · Received 15,620 shares by exercise or conversion ($34.7K) · Sold 38,900 shares ($2.17M) |
| 10 Nov 2026 |
Form 4: Verghese Vikram, Chief Financial Officer
Gave up 2,009 shares to cover exercise price or tax ($105K) · Sold 3,587 shares ($191K) |
| 10 Nov 2026 |
Form 4: Rogers Campbell, Chief Medical Officer
Gave up 2,270 shares to cover exercise price or tax ($119K) |
| 10 Nov 2026 |
Form 4: Jones Marie L., Chief Accounting Officer
Received 795 shares as a grant or award ($15.7K) · Gave up 568 shares to cover exercise price or tax ($29.8K) |
| 10 Nov 2026 | 144 |
| 09 Nov 2026 | 144 |
| 26 Oct 2026 |
Form 4: Rogers Campbell, Chief Medical Officer
Received 17,430 shares by exercise or conversion ($114K) · Sold 23,933 shares ($1.32M) |
| 22 Oct 2026 | 144 |
| 22 Oct 2026 | 144 |
| 14 Oct 2026 |
Form 4: Farquhar John C.m., Director
Sold 38,900 shares ($1.93M) |
| 13 Oct 2026 | 144 |
| 21 Sep 2026 |
Form 4: Rogers Campbell, Chief Medical Officer
Received 13,179 shares by exercise or conversion ($105K) · Sold 19,682 shares ($987K) |
| 18 Sep 2026 |
Form 4: Verghese Vikram, Chief Financial Officer
Sold 7,579 shares ($380K) · Sold 16,766 shares ($851K) |
| 18 Sep 2026 | 144 |
| 18 Sep 2026 | 144 |
| 18 Sep 2026 | 144 |
Loading...